| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/17/2008 | WO2008044798A1 Agent for introducing protein into cell |
| 04/17/2008 | WO2008044754A1 Prophylactic or therapeutic agent for cancer |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008044379A1 Bone loss model animal |
| 04/17/2008 | WO2008043777A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | WO2008015339A3 Recombinant factor vii composition |
| 04/17/2008 | WO2007095338A3 Functional antibodies |
| 04/17/2008 | WO2007084764A8 Selective activation of protoxins through combinatorial targeting |
| 04/17/2008 | WO2004067709A8 Identification of essential genes of aspergillus fumigatus and methods of use |
| 04/17/2008 | WO1999001471A9 Nik proteins, nucleic acids and methods |
| 04/17/2008 | US20080092252 Enhanced Expression |
| 04/17/2008 | US20080090900 Antibiotic bushrin |
| 04/17/2008 | US20080090776 Obtained from lung cancer patients; cDNA and genomic DNA of a novel fusion polynucleotide of an EML4 gene fused with an ALK gene as kinase (EML4-ALK fusion polynucleotide variant 1); for screening a therapeutic agent for cancer, treating cancer |
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090745 Host cells with inactivated protease genes; point mutations; cultures; laundry detergents |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080090257 Compositions and methods for inhibiting or inducing adipogenesis |
| 04/17/2008 | US20080090249 Ube2g2 Binding Domain in The Ubiquitin Ligase Gp78 And Methods Of Use Thereof |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089899 Streptococcus pneumoniae proteins and nucleic |
| 04/17/2008 | US20080089893 therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies; Anticancer agent |
| 04/17/2008 | US20080089890 Methods of polypeptide production |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089886 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/17/2008 | US20080089885 Anti-cd20 antibodies and methods of use |
| 04/17/2008 | US20080089837 monoclonal antibodies directed to the antigen Platelet derived growth factor-alpha |
| 04/17/2008 | CA2703466A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 04/17/2008 | CA2666249A1 Agent for preventing/treating cancer |
| 04/17/2008 | CA2652392A1 Culture method for obtaining a clonal population of antigen-specific b cells |
| 04/16/2008 | EP1911850A1 Method of producing 6-thio-sialylated glycoproteins and glycoconjugates |
| 04/16/2008 | EP1911841A1 Methods for production of proteins |
| 04/16/2008 | EP1911840A1 tRNA SYNTHESIS METHOD, NUCLEIC ACID, AMINOACYL tRNA SYNTHESIS METHOD, AND PROCESS FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN |
| 04/16/2008 | EP1911839A1 Peptide-forming enzyme gene, peptide-forming enzyme, and dipeptide producing method |
| 04/16/2008 | EP1911767A2 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 04/16/2008 | EP1911764A1 Growth-stimulating polypeptides for use in fish and crustaceans |
| 04/16/2008 | EP1911459A1 Lymphangiogenesis promoter |
| 04/16/2008 | EP1910829A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 04/16/2008 | EP1910550A2 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 04/16/2008 | EP1910530A2 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/16/2008 | EP1910414A2 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 04/16/2008 | EP1909895A2 Tandem cardiac pacemaker system |
| 04/16/2008 | EP1909831A2 Self-buffering protein formulations |
| 04/16/2008 | EP1385885B1 Fragments of the retinoic acid-related orphan receptor (ror) comprising the ligand binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1169353B1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/16/2008 | EP1100828B1 Methods for making antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | CN101163718A Reagents that bind ccx-ckr2 |
| 04/16/2008 | CN101163717A Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| 04/16/2008 | CN101163501A Bispecific binding agents for modulating biological activity |
| 04/16/2008 | CN101161817A Genes for the biosynthesis of epothilones |
| 04/16/2008 | CN100381528C Preparation method of undenatured fish scale collagen |
| 04/16/2008 | CA2567394A1 Glycoprotein vi antibodies and methods of use thereof |
| 04/15/2008 | US7358355 Antibodies against human parathyroid hormone related protein |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358352 Tumor necrosis factor; isolating protein from cell culture; use in drug discovery screens compounds that block synthesis |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358350 Oncogene, recombinant protein derived therefrom, and uses thereof |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358339 PRO polypeptide without the N-terminal signal sequence and/or the initiating methionine is encoded by a nucleotide sequence |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358331 Truncated fragments of alpha-synuclein in Lewy body disease |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358228 Methods of treating pain using neurotrophic factors |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358067 Genetic engineering; forming protein, peptide, polypeptide |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358057 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 04/15/2008 | US7357365 Extendable/retractable support column |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/15/2008 | CA2181042C Bacterial receptor structures |
| 04/15/2008 | CA2171614C Pharmaceutical composition containing sialic acid derivatives |
| 04/15/2008 | CA2169764C Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 04/15/2008 | CA2082155C Swine pneumonia vaccine and method of preparation |
| 04/10/2008 | WO2008043102A2 Vasoactive intestinal polypeptide compositions |
| 04/10/2008 | WO2008041863A1 Novel genes and polypeptides associated with insecticidal activity |
| 04/10/2008 | WO2008040469A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040060A1 Vlp based vaccine delivery system |
| 04/10/2008 | WO2007136585A3 Immunotherapeutic compositions and methods |
| 04/10/2008 | WO2007103523A9 Antioxidant protein, compositions, and methods of use |
| 04/10/2008 | WO2007092252A3 Long-acting polypeptides and methods of producing same |
| 04/10/2008 | WO2007084715A3 Tat-031 and methods of assessing and treating cancer |
| 04/10/2008 | WO2007067828A3 Glp-2 mimetibodies, polypeptides, compositions, methods and uses |
| 04/10/2008 | US20080086782 Method for Preparing Modified Collagen Outside a Host Cell |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085854 Fusion proteins of protease inhibitors are provided, in particular fusion proteins of alpha 1-antitrypsin (AAT) and a second protease inhibitor, such as secretory leukocyte protease inhibitor (SLPI) or tissue inhibitor of metalloproteases (TIMP). Polynucleotides encoding the fusion proteins, vectors |
| 04/10/2008 | US20080085853 nuclear delivery construct comprises (i) protein H or a fragment or derivative thereof that is capable of being targeted to the nucleus of a eukaryotic cell; |
| 04/10/2008 | US20080085835 Rps gene family, primers, probes and detection methods |
| 04/10/2008 | US20080085540 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 04/10/2008 | US20080085539 Expression vector comprising yeast secretory leader sequence, biotin acceptor site for golgi-localized biotin ligase and yeast replication origin for use as tool in expression of heterologous gene sequences in yeast cells |
| 04/10/2008 | US20080085538 Methods for Expression and Purification of Recombinant Human Growth Hormone |